Assignee
INTREXON ACTOBIOTICS NV
BE·17 granted patents·1 pending application·11 citations·filing 2012–2022
Top patents by PatentIndex Score
18 records- 0184US10793825B2Modified gram positive bacteria and uses thereofINTREXON ACTOBIOTICS NV·Filed 2019·Granted Oct 6, 2020·0 cites·20 claims
- 0283US10030234B2Modified gram positive bacteria and uses thereofINTREXON ACTOBIOTICS NV·Filed 2016·Granted Jul 24, 2018·2 cites·18 claims
- 0381US9347036B2Modified gram positive bacteria and uses thereofINTREXON ACTOBIOTICS NV·Filed 2012·Granted May 24, 2016·4 cites·14 claims
- 0479US12359210B2Genetically modified bacteria stably expressing IL-10 and insulinINTREXON ACTOBIOTICS NV·Filed 2022·Granted Jul 15, 2025·0 cites·14 claims
- 0579US9982228B2Modified gram positive bacteria and uses thereofINTREXON ACTOBIOTICS NV·Filed 2016·Granted May 29, 2018·2 cites·18 claims
- 0677US9539291B2Induction of mucosal tolerance to antigensINTREXON ACTOBIOTICS NV·Filed 2014·Granted Jan 10, 2017·2 cites·43 claims
- 0776US10519418B2Modified gram positive bacteria and uses thereofINTREXON ACTOBIOTICS NV·Filed 2018·Granted Dec 31, 2019·1 cites·38 claims
- 0872US10668136B2Treatment of immune disease by mucosal delivery of antigens using genetically modified LactococcusINTREXON ACTOBIOTICS NV·Filed 2018·Granted Jun 2, 2020·0 cites·16 claims
- 0969US11633438B2Cryoprotectants for freeze drying of lactic acid bacteriaINTREXON ACTOBIOTICS NV·Filed 2020·Granted Apr 25, 2023·0 cites·22 claims
- 1069US9458467B2Modified gram positive bacteria and uses thereofINTREXON ACTOBIOTICS NV·Filed 2012·Granted Oct 4, 2016·0 cites·25 claims
- 1167US2021163961A1Polycistronic expression system for bacteriaINTREXON ACTOBIOTICS NV·Filed 2020·Application pending·0 cites
- 1265US10988770B2Polycistronic expression system for bacteriaINTREXON ACTOBIOTICS NV·Filed 2018·Granted Apr 27, 2021·0 cites·44 claims
- 1364US9526750B2Induction of mucosal tolerance to antigensINTREXON ACTOBIOTICS NV·Filed 2014·Granted Dec 27, 2016·0 cites·30 claims
- 1462US10385351B2Method to improve Lactococcus preservationINTREXON ACTOBIOTICS NV·Filed 2017·Granted Aug 20, 2019·0 cites·15 claims
- 1561US10596207B2Cryoprotectants for freeze drying of lactic acid bacteriaINTREXON ACTOBIOTICS NV·Filed 2017·Granted Mar 24, 2020·0 cites·19 claims
- 1661US10195269B2Induction of mucosal tolerance to antigensINTREXON ACTOBIOTICS NV·Filed 2016·Granted Feb 5, 2019·0 cites·29 claims
- 1761US10143729B2Treatment of immune disease by mucosal delivery of antigens using genetically modified LactococcusINTREXON ACTOBIOTICS NV·Filed 2013·Granted Dec 4, 2018·0 cites·33 claims
- 1858US9790510B2Method to improve Lactococcus preservationINTREXON ACTOBIOTICS NV·Filed 2015·Granted Oct 17, 2017·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when INTREXON ACTOBIOTICS NV files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →